Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
DaVita price target raised to $150 from $105 at Deutsche Bank » 07:15
01/13/21
01/13
07:15
01/13/21
07:15
DVA

DaVita

$124.06 /

+0.945 (+0.77%)

, HUM

Humana

$422.59 /

-10.73 (-2.48%)

Deutsche Bank analyst…

Deutsche Bank analyst Pito Chickering raised the firm's price target on DaVita (DVA) to $150 from $105 and keeps a Buy rating on the shares. According to the Physician Finder on Humana's (HUM) website, DaVita has gone back in network with Humana for 2021, Chickering tells investors in a research note. The analyst had suspected that Humana wanted DaVita to be out-of-network during the open enrollment period to limit the number of ESRD patients enrolled for 2021. Chickering believes DVA going back in network should alleviate investor concerns around "any radical pricing changes."

ShowHide Related Items >><<
HUM Humana
$422.59 /

-10.73 (-2.48%)

DVA DaVita
$124.06 /

+0.945 (+0.77%)

DVA DaVita
$124.06 /

+0.945 (+0.77%)

01/05/21 Truist
DaVita price target raised to $130 from $100 at Truist
01/05/21 BofA
BofA sees tailwinds for healthcare facilities, names HCA Healthcare top pick
01/05/21 BofA
DaVita downgraded to Neutral from Buy at BofA
07/31/20 Truist
DaVita price target raised to $100 from $90 at SunTrust
HUM Humana
$422.59 /

-10.73 (-2.48%)

01/06/21 Argus
Humana price target raised to $450 from $430 at Argus
01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
01/04/21 RBC Capital
Humana upgraded to Outperform from Sector Perform at RBC Capital
HUM Humana
$422.59 /

-10.73 (-2.48%)

DVA DaVita
$124.06 /

+0.945 (+0.77%)

HUM Humana
$422.59 /

-10.73 (-2.48%)

HUM Humana
$422.59 /

-10.73 (-2.48%)

DVA DaVita
$124.06 /

+0.945 (+0.77%)

Over a week ago
Recommendations
Humana price target raised to $450 from $430 at Argus » 07:13
01/06/21
01/06
07:13
01/06/21
07:13
HUM

Humana

$413.44 /

+1.27 (+0.31%)

Argus analyst David Toung…

Argus analyst David Toung raised the firm's price target on Humana to $450 from $430 and keeps a Buy rating on the shares. The company is benefiting from an aging U.S. population that is seeking secure medical and insurance benefits during retirement, the analyst tells investors in a research note, adding that Humana is also facing rising medical utilization as medical claims increase and elective procedural volumes recover from their pandemic lows.

ShowHide Related Items >><<
HUM Humana
$413.44 /

+1.27 (+0.31%)

HUM Humana
$413.44 /

+1.27 (+0.31%)

01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
01/04/21 RBC Capital
Humana upgraded to Outperform from Sector Perform at RBC Capital
12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
HUM Humana
$413.44 /

+1.27 (+0.31%)

HUM Humana
$413.44 /

+1.27 (+0.31%)

HUM Humana
$413.44 /

+1.27 (+0.31%)

Earnings
Humana backs FY20 adjusted EPS view $18.50-$18.75, consensus $18.67 » 08:41
01/05/21
01/05
08:41
01/05/21
08:41
HUM

Humana

$411.81 /

+1.66 (+0.40%)

During upcoming…

During upcoming conferences, Humana intends to address its prospects and performance and intends to reaffirm its guidance range of $24.70 to $24.95 in diluted earnings per common share, or a range of $18.50 to $18.75 in adjusted earnings per common share, in each case for the year ending December 31, 2020. FY 2020 EPS guidance reflects fourth quarter 2020 losses of approximately $2.55 EPS, or approximately $2.40 in Adjusted EPS. This guidance is consistent with the guidance issued in Humana's press release dated November 3, 2020 and reaffirmed on December 1, 2020.

ShowHide Related Items >><<
HUM Humana
$411.81 /

+1.66 (+0.40%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
01/04/21 RBC Capital
Humana upgraded to Outperform from Sector Perform at RBC Capital
12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
HUM Humana
$411.81 /

+1.66 (+0.40%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

Earnings
Humana backs Q4 adjusted EPS view ($2.40), consensus ($2.37)  08:40
01/05/21
01/05
08:40
01/05/21
08:40
HUM

Humana

$411.81 /

+1.66 (+0.40%)

 
ShowHide Related Items >><<
HUM Humana
$411.81 /

+1.66 (+0.40%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
01/04/21 RBC Capital
Humana upgraded to Outperform from Sector Perform at RBC Capital
12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
HUM Humana
$411.81 /

+1.66 (+0.40%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

Conference/Events
Goldman Sachs to hold a virtual conference » 08:38
01/05/21
01/05
08:38
01/05/21
08:38
A

Agilent

$118.61 /

+0.478 (+0.40%)

, ABC

AmerisourceBergen

$96.48 /

-1.305 (-1.33%)

, BMRN

BioMarin

$86.18 /

-1.51 (-1.72%)

, BSX

Boston Scientific

$35.26 /

-0.69 (-1.92%)

, GSK

GlaxoSmithKline

$37.73 /

+0.94 (+2.56%)

, HUM

Humana

$411.81 /

+1.66 (+0.40%)

, MCK

McKesson

$174.40 /

+0.59 (+0.34%)

, MRNA

Moderna

$111.73 /

+7.4 (+7.09%)

, SAGE

Sage Therapeutics

$85.73 /

-0.76 (-0.88%)

, SGEN

Seagen

$168.44 /

-6.71 (-3.83%)

, TMO

Thermo Fisher

$471.80 /

+5.96 (+1.28%)

13th Annual Healthcare…

13th Annual Healthcare CEOs Unscripted Virtual Conference will be held on January 5. Webcast Link

ShowHide Related Items >><<
TMO Thermo Fisher
$471.80 /

+5.96 (+1.28%)

SGEN Seagen
$168.44 /

-6.71 (-3.83%)

SAGE Sage Therapeutics
$85.73 /

-0.76 (-0.88%)

MRNA Moderna
$111.73 /

+7.4 (+7.09%)

MCK McKesson
$174.40 /

+0.59 (+0.34%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

GSK GlaxoSmithKline
$37.73 /

+0.94 (+2.56%)

BSX Boston Scientific
$35.26 /

-0.69 (-1.92%)

BMRN BioMarin
$86.18 /

-1.51 (-1.72%)

ABC AmerisourceBergen
$96.48 /

-1.305 (-1.33%)

A Agilent
$118.61 /

+0.478 (+0.40%)

A Agilent
$118.61 /

+0.478 (+0.40%)

12/10/20 SVB Leerink
Agilent price target raised to $130 from $120 at SVB Leerink
12/02/20 Goldman Sachs
Agilent initiated with a Buy at Goldman Sachs
11/25/20
Fly Intel: Top five analyst upgrades
11/25/20 UBS
Agilent upgraded to Buy from Neutral at UBS
ABC AmerisourceBergen
$96.48 /

-1.305 (-1.33%)

11/18/20 Jefferies
Drug distributors' pullback on Amazon news an overreaction, says Jefferies
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
11/13/20 Mizuho
AmerisourceBergen price target raised to $104 from $100 at Mizuho
11/09/20 Credit Suisse
AmerisourceBergen price target raised to $123 from $118 at Credit Suisse
BMRN BioMarin
$86.18 /

-1.51 (-1.72%)

12/21/20 Piper Sandler
BioMarin data today should ease approvability concerns, says Piper Sandler
12/17/20 JPMorgan
BioMarin remains 'highest conviction name' at JPMorgan
11/03/20 Piper Sandler
Piper Sandler remains buyer of BioMarin after vosoritide submission
10/22/20 RBC Capital
uniQure initiated with an Outperform at RBC Capital
BSX Boston Scientific
$35.26 /

-0.69 (-1.92%)

12/23/20 Piper Sandler
Boston Scientific a name to own at current share levels, says Piper Sandler
12/15/20 Goldman Sachs
Boston Scientific downgraded to Buy from Conviction Buy at Goldman Sachs
12/15/20 Goldman Sachs
Medtronic upgraded to Neutral from Sell at Goldman Sachs
11/18/20 Truist
Boston Scientific price target lowered to $44 from $47 at Truist
GSK GlaxoSmithKline
$37.73 /

+0.94 (+2.56%)

12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
12/08/20 JPMorgan
GlaxoSmithKline price target lowered to 1,500 GBp from 1,650 GBp at JPMorgan
12/03/20
Fly Intel: Top five analyst downgrades
12/03/20 UBS
GlaxoSmithKline downgraded to Neutral from Buy at UBS
HUM Humana
$411.81 /

+1.66 (+0.40%)

01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
01/04/21 RBC Capital
Humana upgraded to Outperform from Sector Perform at RBC Capital
12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
MCK McKesson
$174.40 /

+0.59 (+0.34%)

12/24/20 Morgan Stanley
Morgan Stanley sees greater FY22 COVID vaccine opportunity at McKesson
11/18/20 Goldman Sachs
McKesson upgraded to Conviction Buy from Buy at Goldman Sachs
MRNA Moderna
$111.73 /

+7.4 (+7.09%)

01/04/21 Piper Sandler
Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler
12/31/20 Ladenburg
UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg
12/29/20 Citi
Arcturus selloff brings 'very good' buying opportunity, says Citi
12/24/20 Piper Sandler
Piper calls Inovio's COVID vaccine candidate 'an also-ran' after data published
SAGE Sage Therapeutics
$85.73 /

-0.76 (-0.88%)

01/04/21
Sage Therapeutics downgraded to Sector Perform at RBC Capital on valuation
01/04/21 Guggenheim
Sage Therapeutics upgraded to Buy from Neutral at Guggenheim
01/04/21 RBC Capital
Sage Therapeutics downgraded to Sector Perform from Outperform at RBC Capital
12/04/20
Fly Intel: Top five analyst upgrades
SGEN Seagen
$168.44 /

-6.71 (-3.83%)

10/13/20 JMP Securities
Seagen price target raised to $216 from $200 at JMP Securities
09/22/20 Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/22/20 JMP Securities
Seattle Genetics price target raised to $200 from $185 at JMP Securities
09/21/20 Piper Sandler
Tisotumab data sets Seattle Genetics up for another approval, says Piper Sandler
TMO Thermo Fisher
$471.80 /

+5.96 (+1.28%)

12/17/20 BTIG
Illumina upgraded to Buy from Neutral at BTIG
12/16/20 Citi
Thermo Fisher downgraded to Neutral from Buy at Citi
12/10/20 Exane BNP Paribas
Qiagen price target raised to EUR 54 from EUR 52 at Exane BNP Paribas
12/09/20 KeyBanc
Catalent upgraded to Overweight upon assumption at KeyBanc
TMO Thermo Fisher
$471.80 /

+5.96 (+1.28%)

SGEN Seagen
$168.44 /

-6.71 (-3.83%)

SAGE Sage Therapeutics
$85.73 /

-0.76 (-0.88%)

MRNA Moderna
$111.73 /

+7.4 (+7.09%)

MCK McKesson
$174.40 /

+0.59 (+0.34%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

GSK GlaxoSmithKline
$37.73 /

+0.94 (+2.56%)

BSX Boston Scientific
$35.26 /

-0.69 (-1.92%)

BMRN BioMarin
$86.18 /

-1.51 (-1.72%)

ABC AmerisourceBergen
$96.48 /

-1.305 (-1.33%)

A Agilent
$118.61 /

+0.478 (+0.40%)

  • 22
    May
  • 19
    May
  • 12
    Feb
TMO Thermo Fisher
$471.80 /

+5.96 (+1.28%)

MRNA Moderna
$111.73 /

+7.4 (+7.09%)

MCK McKesson
$174.40 /

+0.59 (+0.34%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

GSK GlaxoSmithKline
$37.73 /

+0.94 (+2.56%)

BSX Boston Scientific
$35.26 /

-0.69 (-1.92%)

ABC AmerisourceBergen
$96.48 /

-1.305 (-1.33%)

TMO Thermo Fisher
$471.80 /

+5.96 (+1.28%)

SGEN Seagen
$168.44 /

-6.71 (-3.83%)

SAGE Sage Therapeutics
$85.73 /

-0.76 (-0.88%)

MRNA Moderna
$111.73 /

+7.4 (+7.09%)

MCK McKesson
$174.40 /

+0.59 (+0.34%)

HUM Humana
$411.81 /

+1.66 (+0.40%)

GSK GlaxoSmithKline
$37.73 /

+0.94 (+2.56%)

BSX Boston Scientific
$35.26 /

-0.69 (-1.92%)

BMRN BioMarin
$86.18 /

-1.51 (-1.72%)

ABC AmerisourceBergen
$96.48 /

-1.305 (-1.33%)

A Agilent
$118.61 /

+0.478 (+0.40%)

TMO Thermo Fisher
$471.80 /

+5.96 (+1.28%)

MRNA Moderna
$111.73 /

+7.4 (+7.09%)

MCK McKesson
$174.40 /

+0.59 (+0.34%)

GSK GlaxoSmithKline
$37.73 /

+0.94 (+2.56%)

BSX Boston Scientific
$35.26 /

-0.69 (-1.92%)

BMRN BioMarin
$86.18 /

-1.51 (-1.72%)

ABC AmerisourceBergen
$96.48 /

-1.305 (-1.33%)

A Agilent
$118.61 /

+0.478 (+0.40%)

Hot Stocks
CVS Health up 1% after Amazon-Berkshire-JPMorgan JV said to disband » 12:33
01/04/21
01/04
12:33
01/04/21
12:33
CI

Cigna

$201.05 /

-7.13 (-3.42%)

, CNC

Centene

$60.40 /

+0.33 (+0.55%)

, CVS

CVS Health

$68.36 /

+0.06 (+0.09%)

, HUM

Humana

$401.44 /

-8.71 (-2.12%)

, UNH

UnitedHealth

$341.00 /

-9.86 (-2.81%)

, WCG

WellCare

$350.01 /

+ (+0.00%)

, HNT

Health Net

$0.00 /

+ (+0.00%)

, MOH

Molina Healthcare

$211.45 /

-1.6 (-0.75%)

, ANTM

Anthem

$312.22 /

-8.97 (-2.79%)

, JPM

JPMorgan

$125.33 /

-1.66 (-1.31%)

, AMZN

Amazon.com

$3,157.05 /

-100.155 (-3.07%)

, BRK.A

Berkshire Hathaway

$341,500.00 /

-6702 (-1.92%)

Shares of CVS Health…

Shares of CVS Health (CVS) are up about 1% in afternoon trading after CNBC reported that Haven, the joint venture that Amazon (AMZN), Berkshire Hathaway (BRK.A) and JPMorgan (JPM) had launched with an eye on disrupting the existing healthcare model, will shut down by the end of next month. Other publicly traded companies in the healthcare insurance space that could react to the Haven news include Anthem (ANTM), Centene (CNC), Cigna (CI), Health Net (HNT), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).

ShowHide Related Items >><<
UNH UnitedHealth
$341.00 /

-9.86 (-2.81%)

MOH Molina Healthcare
$211.45 /

-1.6 (-0.75%)

JPM JPMorgan
$125.33 /

-1.66 (-1.31%)

HUM Humana
$401.44 /

-8.71 (-2.12%)

CVS CVS Health
$68.36 /

+0.06 (+0.09%)

CNC Centene
$60.40 /

+0.33 (+0.55%)

CI Cigna
$201.05 /

-7.13 (-3.42%)

BRK.A Berkshire Hathaway
$341,500.00 /

-6702 (-1.92%)

ANTM Anthem
$312.22 /

-8.97 (-2.79%)

AMZN Amazon.com
$3,157.05 /

-100.155 (-3.07%)

CI Cigna
$201.05 /

-7.13 (-3.42%)

12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
12/18/20 Mizuho
Cigna price target raised to $229 from $220 at Mizuho
11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
11/17/20 Piper Sandler
Amazon entry into Pharmacy makes 'great deal of sense,' says Piper Sandler
CNC Centene
$60.40 /

+0.33 (+0.55%)

01/04/21 Cowen
Centene deal for Magellan makes 'strategic sense,' says Cowen
12/21/20 Deutsche Bank
Centene price target lowered to $77 from $83 at Deutsche Bank
11/16/20 Citi
Citi opens 'negative catalyst watch' on Centene
CVS CVS Health
$68.36 /

+0.06 (+0.09%)

11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
11/11/20 Piper Sandler
CVS Health price target raised to $76 from $72 at Piper Sandler
HUM Humana
$401.44 /

-8.71 (-2.12%)

01/04/21
Fly Intel: Top five analyst upgrades
01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
01/04/21 RBC Capital
Humana upgraded to Outperform from Sector Perform at RBC Capital
UNH UnitedHealth
$341.00 /

-9.86 (-2.81%)

12/03/20 Deutsche Bank
UnitedHealth price target raised to $359 from $332 at Deutsche Bank
12/02/20 BMO Capital
UnitedHealth price target raised to $395 from $385 at BMO Capital
12/02/20 Truist
UnitedHealth price target raised to $400 from $380 at Truist
WCG WellCare
$350.01 /

+ (+0.00%)

09/21/20 Citi
Citi sees ACA remaining law despite Ginsburg death
03/04/20 Jefferies
Centene 2020 EPS view hurt by possible NY rate cut, says Jefferies
02/05/20 Credit Suisse
Centene price target raised to $72.50 from $65 at Credit Suisse
01/10/20 Piper Sandler
WellCare downgraded to Neutral from Overweight at Piper Sandler
HNT Health Net
$0.00 /

+ (+0.00%)

MOH Molina Healthcare
$211.45 /

-1.6 (-0.75%)

11/11/20 Piper Sandler
Molina Healthcare price target raised to $266 from $213 at Piper Sandler
10/13/20 Truist
Truist raises price targets on select Healthcare Services names
09/30/20 Truist
Molina Healthcare risk-reward attractive after Affinity Health deal, says Truist
ANTM Anthem
$312.22 /

-8.97 (-2.79%)

12/18/20 Mizuho
Anthem price target raised to $320 from $300 at Mizuho
11/11/20 Piper Sandler
Anthem price target raised to $369 from $330 at Piper Sandler
11/06/20 JPMorgan
Anthem price target raised to $389 from $324 at JPMorgan
10/29/20 SVB Leerink
Anthem price target raised to $370 from $345 at SVB Leerink
JPM JPMorgan
$125.33 /

-1.66 (-1.31%)

01/04/21 Barclays
JPMorgan price target raised to $164 from $144 at Barclays
12/14/20 Keefe Bruyette
Universal Banks upgraded to Overweight from Market Weight at Keefe Bruyette
12/11/20 Credit Suisse
JPMorgan price target raised to $142 from $126 at Credit Suisse
12/09/20 RBC Capital
JPMorgan price target raised to $130 from $110 at RBC Capital
AMZN Amazon.com
$3,157.05 /

-100.155 (-3.07%)

12/22/20 Wells Fargo
Microsoft's own semis 'a competitive headwind' for Intel, says Wells Fargo
12/16/20 Baird
Baird would be a buyer of Teladoc amid weakness caused by Amazon report
12/14/20 BMO Capital
BMO downgrades Disney after recent run, names new top media pick
12/03/20 Rosenblatt
Ambarella price target raised to $100 from $82 at Rosenblatt
BRK.A Berkshire Hathaway
$341,500.00 /

-6702 (-1.92%)

07/07/20 Argus
Dominion price target lowered to $80 from $87 at Argus
07/06/20 Guggenheim
Guggenheim 'loves' Dominion gas transmission sale, decision to scrap pipeline
04/06/20 Citi
Delta not 'broken story' but share weakness may persist, says Citi
UNH UnitedHealth
$341.00 /

-9.86 (-2.81%)

MOH Molina Healthcare
$211.45 /

-1.6 (-0.75%)

JPM JPMorgan
$125.33 /

-1.66 (-1.31%)

HUM Humana
$401.44 /

-8.71 (-2.12%)

CVS CVS Health
$68.36 /

+0.06 (+0.09%)

CNC Centene
$60.40 /

+0.33 (+0.55%)

CI Cigna
$201.05 /

-7.13 (-3.42%)

BRK.A Berkshire Hathaway
$341,500.00 /

-6702 (-1.92%)

ANTM Anthem
$312.22 /

-8.97 (-2.79%)

AMZN Amazon.com
$3,157.05 /

-100.155 (-3.07%)

UNH UnitedHealth
$341.00 /

-9.86 (-2.81%)

JPM JPMorgan
$125.33 /

-1.66 (-1.31%)

CVS CVS Health
$68.36 /

+0.06 (+0.09%)

CI Cigna
$201.05 /

-7.13 (-3.42%)

BRK.A Berkshire Hathaway
$341,500.00 /

-6702 (-1.92%)

ANTM Anthem
$312.22 /

-8.97 (-2.79%)

AMZN Amazon.com
$3,157.05 /

-100.155 (-3.07%)

UNH UnitedHealth
$341.00 /

-9.86 (-2.81%)

MOH Molina Healthcare
$211.45 /

-1.6 (-0.75%)

JPM JPMorgan
$125.33 /

-1.66 (-1.31%)

HUM Humana
$401.44 /

-8.71 (-2.12%)

CVS CVS Health
$68.36 /

+0.06 (+0.09%)

CNC Centene
$60.40 /

+0.33 (+0.55%)

CI Cigna
$201.05 /

-7.13 (-3.42%)

BRK.A Berkshire Hathaway
$341,500.00 /

-6702 (-1.92%)

ANTM Anthem
$312.22 /

-8.97 (-2.79%)

AMZN Amazon.com
$3,157.05 /

-100.155 (-3.07%)

UNH UnitedHealth
$341.00 /

-9.86 (-2.81%)

JPM JPMorgan
$125.33 /

-1.66 (-1.31%)

CVS CVS Health
$68.36 /

+0.06 (+0.09%)

CNC Centene
$60.40 /

+0.33 (+0.55%)

CI Cigna
$201.05 /

-7.13 (-3.42%)

AMZN Amazon.com
$3,157.05 /

-100.155 (-3.07%)

Upgrade
Fly Intel: Top five analyst upgrades » 10:05
01/04/21
01/04
10:05
01/04/21
10:05
T

AT&T

$29.12 /

+0.365 (+1.27%)

, TAP

Molson Coors

$46.00 /

+0.78 (+1.72%)

, HUM

Humana

$411.00 /

+0.85 (+0.21%)

, MTD

Mettler-Toledo

$1,164.82 /

+24.79 (+2.17%)

, GS

Goldman Sachs

$266.21 /

+2.58 (+0.98%)

, MS

Morgan Stanley

$69.46 /

+0.93 (+1.36%)

, ALLY

Ally Financial

$36.41 /

+0.75 (+2.10%)

Catch up on today's…

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Outperform from Market Perform at Raymond James with analyst Frank Louthan saying while he thinks Q4 is likely to be an unimpressive quarter, the analyst believes the situation improves for AT&T over the next 12 months, offering a solid total return story. 2. Molson Coors (TAP) upgraded to Buy from Hold at Jefferies with analyst Kevin Grundy saying that recovery potential is not adequately reflected in Molson Coors' share price. 3. Humana (HUM) upgraded to Outperform from Sector Perform at RBC Capital with analyst Frank Morgan saying the company is "well positioned" for strong growth in FY21 and beyond as its management anticipates an above-industry average growth in Individual Medicare Advantage. 4. Mettler-Toledo (MTD) upgraded to In Line from Underperform at Evercore ISI with analyst Vijay Kumar noting that the company's 4%-6% revenue growth outlook guided in November "seems conservative" given the strong China and Industrial rebounds in the last cycle" as it assumes a 4%-6% China growth vs. historical trends of 8%-10%. 5. Goldman Sachs (GS), Morgan Stanley (MS) and Ally Financial (ALLY) all upgraded to Overweight from Equal Weight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
TAP Molson Coors
$46.00 /

+0.78 (+1.72%)

T AT&T
$29.12 /

+0.365 (+1.27%)

MTD Mettler-Toledo
$1,164.82 /

+24.79 (+2.17%)

MS Morgan Stanley
$69.46 /

+0.93 (+1.36%)

HUM Humana
$411.00 /

+0.85 (+0.21%)

GS Goldman Sachs
$266.21 /

+2.58 (+0.98%)

ALLY Ally Financial
$36.41 /

+0.75 (+2.10%)

T AT&T
$29.12 /

+0.365 (+1.27%)

01/04/21 Raymond James
AT&T upgraded to Outperform from Market Perform at Raymond James
01/04/21 Raymond James
AT&T upgraded to Outperform from Market Perform at Raymond James
12/24/20 Raymond James
AT&T estimates lowered ahead of Q4 report at Raymond James
12/22/20 JPMorgan
JPMorgan remains 'wary' on AT&T shares despite 'stable' dividend
TAP Molson Coors
$46.00 /

+0.78 (+1.72%)

01/04/21 Jefferies
Jefferies upgrades 'recovery beneficiary' Molson Coors to Buy
01/04/21 Jefferies
Molson Coors upgraded to Buy from Hold at Jefferies
12/07/20 Wells Fargo
Molson Coors initiated with an Equal Weight at Wells Fargo
07/15/20 Bryan Garnier
Molson Coors upgraded to Buy from Sell at Bryan Garnier
HUM Humana
$411.00 /

+0.85 (+0.21%)

01/04/21
Humana upgraded to Outperform at RBC Capital on above-average MA growth
01/04/21 RBC Capital
Humana upgraded to Outperform from Sector Perform at RBC Capital
12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
MTD Mettler-Toledo
$1,164.82 /

+24.79 (+2.17%)

01/04/21
Mettler-Toledo upgraded to In Line at Evercore ISI given strong rebound history
01/04/21 Evercore ISI
Mettler-Toledo upgraded to In Line from Underperform at Evercore ISI
12/17/20 Cleveland Research
Mettler-Toledo upgraded to Buy from Neutral at Cleveland Research
12/16/20 Citi
Mettler-Toledo price target raised to $1,200 from $1,150 at Citi
GS Goldman Sachs
$266.21 /

+2.58 (+0.98%)

01/04/21 Barclays
Goldman Sachs upgraded to Overweight with $362 target at Barclays
01/04/21 Barclays
Goldman Sachs upgraded to Overweight from Equal Weight at Barclays
12/21/20 Morgan Stanley
Goldman Sachs price target raised to $291 from $273 at Morgan Stanley
12/14/20 Keefe Bruyette
Universal Banks upgraded to Overweight from Market Weight at Keefe Bruyette
MS Morgan Stanley
$69.46 /

+0.93 (+1.36%)

01/04/21 Barclays
Morgan Stanley upgraded to Overweight with $88 target at Barclays
01/04/21 Barclays
Morgan Stanley upgraded to Overweight from Equal Weight at Barclays
12/11/20 Credit Suisse
Morgan Stanley price target raised to $74 from $60 at Credit Suisse
ALLY Ally Financial
$36.41 /

+0.75 (+2.10%)

01/04/21 Barclays
Ally Financial upgraded to Overweight with $48 target at Barclays
01/04/21 Barclays
Ally Financial upgraded to Overweight from Equal Weight at Barclays
12/21/20
Fly Intel: Top five analyst initiations
12/21/20 RBC Capital
Ally Financial initiated with an Outperform at RBC Capital
TAP Molson Coors
$46.00 /

+0.78 (+1.72%)

T AT&T
$29.12 /

+0.365 (+1.27%)

MTD Mettler-Toledo
$1,164.82 /

+24.79 (+2.17%)

MS Morgan Stanley
$69.46 /

+0.93 (+1.36%)

HUM Humana
$411.00 /

+0.85 (+0.21%)

GS Goldman Sachs
$266.21 /

+2.58 (+0.98%)

ALLY Ally Financial
$36.41 /

+0.75 (+2.10%)

T AT&T
$29.12 /

+0.365 (+1.27%)

MS Morgan Stanley
$69.46 /

+0.93 (+1.36%)

HUM Humana
$411.00 /

+0.85 (+0.21%)

GS Goldman Sachs
$266.21 /

+2.58 (+0.98%)

TAP Molson Coors
$46.00 /

+0.78 (+1.72%)

T AT&T
$29.12 /

+0.365 (+1.27%)

MS Morgan Stanley
$69.46 /

+0.93 (+1.36%)

HUM Humana
$411.00 /

+0.85 (+0.21%)

GS Goldman Sachs
$266.21 /

+2.58 (+0.98%)

ALLY Ally Financial
$36.41 /

+0.75 (+2.10%)

TAP Molson Coors
$46.00 /

+0.78 (+1.72%)

T AT&T
$29.12 /

+0.365 (+1.27%)

MS Morgan Stanley
$69.46 /

+0.93 (+1.36%)

GS Goldman Sachs
$266.21 /

+2.58 (+0.98%)

ALLY Ally Financial
$36.41 /

+0.75 (+2.10%)

Upgrade
Humana upgraded to Outperform at RBC Capital on above-average MA growth » 08:55
01/04/21
01/04
08:55
01/04/21
08:55
HUM

Humana

$410.15 /

+3.48 (+0.86%)

As previously reported,…

As previously reported, RBC Capital analyst Frank Morgan upgraded Humana to Outperform from Sector Perform with a price target of $479, up from $429. The company is "well positioned" for strong growth in FY21 and beyond as its management anticipates an above-industry average growth in Individual Medicare Advantage, the analyst tells investors in a research note. Humana should also continue to benefit from improved operating leverage and efficiency initiatives, Morgan adds, boosting his FY21 EPS view to $21.78 from $21.42.

ShowHide Related Items >><<
HUM Humana
$410.15 /

+3.48 (+0.86%)

HUM Humana
$410.15 /

+3.48 (+0.86%)

01/04/21 RBC Capital
Humana upgraded to Outperform from Sector Perform at RBC Capital
12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
11/30/20 SVB Leerink
Humana price target lowered to $500 from $505 at SVB Leerink
HUM Humana
$410.15 /

+3.48 (+0.86%)

HUM Humana
$410.15 /

+3.48 (+0.86%)

HUM Humana
$410.15 /

+3.48 (+0.86%)

Upgrade
Humana upgraded to Outperform from Sector Perform at RBC Capital » 05:43
01/04/21
01/04
05:43
01/04/21
05:43
HUM

Humana

$410.15 /

+3.48 (+0.86%)

RBC Capital analyst Frank…

RBC Capital analyst Frank Morgan upgraded Humana to Outperform from Sector Perform with a $479 price target.

ShowHide Related Items >><<
HUM Humana
$410.15 /

+3.48 (+0.86%)

HUM Humana
$410.15 /

+3.48 (+0.86%)

12/22/20 JPMorgan
Latest Georgia polling favors Republicans, says JPMorgan
12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
11/30/20 SVB Leerink
Humana price target lowered to $500 from $505 at SVB Leerink
11/04/20 Oppenheimer
Humana price target raised to $460 from $440 at Oppenheimer
HUM Humana
$410.15 /

+3.48 (+0.86%)

HUM Humana
$410.15 /

+3.48 (+0.86%)

HUM Humana
$410.15 /

+3.48 (+0.86%)

Recommendations
Latest Georgia polling favors Republicans, says JPMorgan » 09:32
12/22/20
12/22
09:32
12/22/20
09:32
HUM

Humana

$388.93 /

-2.69 (-0.69%)

, CNC

Centene

$58.66 /

-2.41 (-3.95%)

, UNH

UnitedHealth

$336.42 /

-2.37 (-0.70%)

, ATHM

Autohome

$98.15 /

-0.83 (-0.84%)

, CI

Cigna

$197.37 /

+0.36 (+0.18%)

, MOH

Molina Healthcare

$202.09 /

+0.41 (+0.20%)

The latest Real Clear…

The latest Real Clear Politics polling averages increasingly favor the Republican Senate candidates in Georgia, JPMorgan analyst Gary Taylor tells investors in a research note. Betting markets currently give Republicans 76% odds, versus 68% last week, of winning at least one of the two seats, the analyst adds. Taylor sees the January 5 vote as a "miniature new clearing event" for Managed Care sector valuations, sentiment and performance. Humana (HUM) shares and the sector broadly would likely benefit most from a Republican win, while Centene (CNC) shares would likely benefit most from a Democratic sweep, says Taylor.

ShowHide Related Items >><<
UNH UnitedHealth
$336.42 /

-2.37 (-0.70%)

MOH Molina Healthcare
$202.09 /

+0.41 (+0.20%)

HUM Humana
$388.93 /

-2.69 (-0.69%)

CNC Centene
$58.66 /

-2.41 (-3.95%)

CI Cigna
$197.37 /

+0.36 (+0.18%)

ATHM Autohome
$98.15 /

-0.83 (-0.84%)

HUM Humana
$388.93 /

-2.69 (-0.69%)

12/17/20 Canaccord
SI-Bone price target raised to $34 from $30 at Canaccord
11/30/20 SVB Leerink
Humana price target lowered to $500 from $505 at SVB Leerink
11/04/20 Oppenheimer
Humana price target raised to $460 from $440 at Oppenheimer
11/04/20 Credit Suisse
Humana price target raised to $465 from $423 at Credit Suisse
CNC Centene
$58.66 /

-2.41 (-3.95%)

12/21/20 Deutsche Bank
Centene price target lowered to $77 from $83 at Deutsche Bank
11/16/20 Citi
Citi opens 'negative catalyst watch' on Centene
11/11/20 Piper Sandler
Centene price target raised to $89 from $83 at Piper Sandler
11/02/20 Citi
Citi opens 'positive catalyst watches' on Centene, HCA, Tenet into election
UNH UnitedHealth
$336.42 /

-2.37 (-0.70%)

12/03/20 Deutsche Bank
UnitedHealth price target raised to $359 from $332 at Deutsche Bank
12/02/20 BMO Capital
UnitedHealth price target raised to $395 from $385 at BMO Capital
12/02/20 Truist
UnitedHealth price target raised to $400 from $380 at Truist
12/02/20 Raymond James
UnitedHealth price target raised to $405 from $355 at Raymond James
ATHM Autohome
$98.15 /

-0.83 (-0.84%)

12/01/20 Macquarie
Autohome price target raised to $95 from $90 at Macquarie
11/25/20
Fly Intel: Top five analyst upgrades
11/25/20 Mizuho
Autohome upgraded to Buy from Neutral at Mizuho
10/01/20 Deutsche Bank
Autohome initiated with a Buy at Deutsche Bank
CI Cigna
$197.37 /

+0.36 (+0.18%)

12/18/20 Mizuho
Cigna price target raised to $229 from $220 at Mizuho
11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
11/17/20 Piper Sandler
Amazon entry into Pharmacy makes 'great deal of sense,' says Piper Sandler
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
MOH Molina Healthcare
$202.09 /

+0.41 (+0.20%)

11/11/20 Piper Sandler
Molina Healthcare price target raised to $266 from $213 at Piper Sandler
10/13/20 Truist
Truist raises price targets on select Healthcare Services names
09/30/20 Truist
Molina Healthcare risk-reward attractive after Affinity Health deal, says Truist
09/22/20 Stephens
Molina Healthcare downgraded to Equal Weight from Overweight at Stephens
UNH UnitedHealth
$336.42 /

-2.37 (-0.70%)

MOH Molina Healthcare
$202.09 /

+0.41 (+0.20%)

HUM Humana
$388.93 /

-2.69 (-0.69%)

CNC Centene
$58.66 /

-2.41 (-3.95%)

CI Cigna
$197.37 /

+0.36 (+0.18%)

ATHM Autohome
$98.15 /

-0.83 (-0.84%)

UNH UnitedHealth
$336.42 /

-2.37 (-0.70%)

HUM Humana
$388.93 /

-2.69 (-0.69%)

CI Cigna
$197.37 /

+0.36 (+0.18%)

UNH UnitedHealth
$336.42 /

-2.37 (-0.70%)

MOH Molina Healthcare
$202.09 /

+0.41 (+0.20%)

HUM Humana
$388.93 /

-2.69 (-0.69%)

CNC Centene
$58.66 /

-2.41 (-3.95%)

CI Cigna
$197.37 /

+0.36 (+0.18%)

ATHM Autohome
$98.15 /

-0.83 (-0.84%)

UNH UnitedHealth
$336.42 /

-2.37 (-0.70%)

CNC Centene
$58.66 /

-2.41 (-3.95%)

CI Cigna
$197.37 /

+0.36 (+0.18%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.